261 related articles for article (PubMed ID: 11642086)
21. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N
Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199
[TBL] [Abstract][Full Text] [Related]
22. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
[TBL] [Abstract][Full Text] [Related]
23. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
[TBL] [Abstract][Full Text] [Related]
24. [The immunoreactivity of IgG and its fragments from ITP patients and their effects on platelet aggregation function].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Wang L; Zhang F; Ma DX
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):158-61. PubMed ID: 16792915
[TBL] [Abstract][Full Text] [Related]
25. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
[TBL] [Abstract][Full Text] [Related]
26. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942
[TBL] [Abstract][Full Text] [Related]
27. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
[TBL] [Abstract][Full Text] [Related]
28. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and binding with membrane glycoproteins.
Smirnova IV; Khaspekova SG; Ignatov VV; Mazurov AV
Biochemistry (Mosc); 1998 Jun; 63(6):710-8. PubMed ID: 9668212
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
30. Topographical Association of the Platelet Fc-receptor with the Glycoprotein IIb-IIIa Complex.
Berndt MC; Mazurov AV; Vinogradov DV; Burns GF; Chesterman CN
Platelets; 1993; 4(4):190-6. PubMed ID: 21043840
[TBL] [Abstract][Full Text] [Related]
31. Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patients.
Buist MR; Kenemans P; den Hollander W; Vermorken JB; Molthoff CJ; Burger CW; Helmerhorst TJ; Baak JP; Roos JC
Cancer Res; 1993 Nov; 53(22):5413-8. PubMed ID: 8221680
[TBL] [Abstract][Full Text] [Related]
32. [Expression of antibody Fab against platelet IIb/IIIa in E.coli and characterization of its biological activity].
Yang YC; Lai CN; Wang Y; Shen BF; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):563-7. PubMed ID: 15367348
[TBL] [Abstract][Full Text] [Related]
33. Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
Elgqvist J; Andersson H; Bäck T; Claesson I; Hultborn R; Jensen H; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
Nucl Med Biol; 2006 Nov; 33(8):1065-72. PubMed ID: 17127181
[TBL] [Abstract][Full Text] [Related]
34. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
Arvieux J; Roussel B; Pouzol P; Colomb MG
Thromb Haemost; 1993 Aug; 70(2):336-41. PubMed ID: 8236145
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor.
Coller BS; Scudder LE
Blood; 1985 Dec; 66(6):1456-9. PubMed ID: 2998514
[TBL] [Abstract][Full Text] [Related]
36. [Results of clinical trials of a novel glycoprotein IIb-IIIa antagonist framon in high-risk coronary angioplasty].
Mazurov AV; Pevzner DV; Staroverov II; Samko AN; Antonova OA; Ivanov VA; Abugov SA; Gontuar MG; Chestukhin VV; Vlasik TN; Ruda MIa
Kardiologiia; 2005; 45(5):4-12. PubMed ID: 16007042
[TBL] [Abstract][Full Text] [Related]
37. [Generation of human Fab antibody against platelet membrane glycoprotein IIb/IIIa and its effect on platelet aggregation].
Dong NZ; Cui YJ; Ruan CG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jan; 25(1):65-7. PubMed ID: 19126390
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the antiplatelet agent potential of the whole molecule, F(ab)2 and Fab fragments of humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
Kaku S; Yano S; Kawasaki T; Sakai Y; Suzuki K; Kawamura K; Masuho Y; Satoh N; Takenaka T; Landolfi NF; Co MS
Gen Pharmacol; 1996 Apr; 27(3):435-9. PubMed ID: 8723521
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibalpha inhibit platelet dependent thrombin generation by different mechanisms.
Thomas S; Metcalfe P; Goodall AH; Gray E
Thromb Haemost; 2000 Jul; 84(1):98-103. PubMed ID: 10928478
[TBL] [Abstract][Full Text] [Related]
40. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
Liu CZ; Hur BT; Huang TF
Thromb Haemost; 1996 Oct; 76(4):585-91. PubMed ID: 8903000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]